Jim Cramer on Recursion (RXRX): "The AI Company That Has It - Backed by Jensen Huang and NVIDIA"

By Yahoo! Finance | 1 month ago

Jim Cramer hints at a deeper agenda behind tariffs and discusses Recursion Pharmaceuticals, Inc. He emphasizes the potential impact of FDA policy changes on the small-cap biotech company's AI drug discovery platform.

Did you find this insightful?